The New Albany-based company offers an exercise with a virtual octopus for people recovering from stroke and other ...

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...

DEFY Neuro Rehabilitation launches during Brain Injury Awareness Month with a mission to serve families and strengthen ...

Discover the Benefits of Brain-Based Care in Northern Minnesota Grand Rapids, Aruba - March 8, 2026 / North Lakes ...

TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...

A Chanhassen-based medical company has raised $52 million in its quest to treat an aggressive form of brain cancer. Late last week, Alpheus Medical Inc. announced that it closed its Series B funding ...

For decades, treating major depression has involved a frustrating cycle of trial and error, with patients cycling through medications and therapies while clinicians rely on symptoms and intuition more ...

A recent brain imaging study reveals that attention deficit hyperactivity disorder consists of at least two distinct physical subtypes. This discovery suggests that patients may eventually benefit ...